The 2025 Clinical Trial Supply West Coast conference will gather experts to discuss US trial operations in a shifting tariff ...

Clinical trial failure insurance is turning biotech’s most costly risk into a manageable asset, opening new pathways for ...

The inaugural Outsourcing in Clinical Trials & Clinical Trial Supply China conference will gather experts to discuss China's ...

AbCellera Biologics (ABCL) marks a milestone, transitioning to clinical-stage biotech with ABCL635 dosing and pipeline expansion.

As clinical trials become more complex, success depends on early collaboration, thoughtful protocol design, and practical ...

Discover key insights from Cytokinetics' Q2 2025 earnings call, including aficamten’s regulatory progress, launch plans, clinical milestones, and ...

GAAP EPS loss of $1.71 in Q2 2025 slightly missed the consensus estimate by $0.01; revenue remains at zero (GAAP) in Q2 2025, as expected for a clinical-stage biotech. Operating loss (GAAP) widened to ...

RTP-008, developed based on Raytone’s iSus® bioabsorbable sustained-release drug delivery platform, is a novel ophthalmic therapeutic designed to address the complexities of dry eye disease. The dual ...

Relay Therapeutics beat analyst estimates for both GAAP revenue and earnings per share in Q2 2025. The company reported continued clinical advancement of its lead asset RLY-2608, with new positive ...

Raytone Biotech begins patient dosing in clinical trial of RTP-008 to treat dry eye disease: Beijing Tuesday, August 5, 2025, 13:00 Hrs [IST] Raytone Biotech, a clinical-stage bio ...

A modified version of a diet known to lower blood pressure is also effective at lowering glucose in adults with type 2 diabetes, according to a clinical trial led by researchers at the Johns Hopkins ...

TransMedics Group shares surged after the company said the Food and Drug Administration has granted conditional approval of its investigational device exemption, letting the company proceed with its ...